Page last updated: 2024-08-17

mannitol and Central Nervous System Neoplasm

mannitol has been researched along with Central Nervous System Neoplasm in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Ambady, P; Lin, P; Lujan, BJ; Neuwelt, EA; Simonett, JM; Skalet, AH1
Burks, SR; Frank, JA; Kersch, CN; Muldoon, LL; Neuwelt, EA; Pagel, MA; Sundby, M; Witko, JA1
Alahuhta, S; Isokangas, M; Keinänen, T; Kiviniemi, V; Korhonen, V; Kortelainen, J; Kuittinen, O; Myllylä, T; Nikkinen, J; Rytky, S; Siniluoto, T; Sonkajärvi, E; Tervonen, O; Tuovinen, T; Turpeenniemi-Hujanen, T; Voipio, J1
Alahuhta, S; Isokangas, M; Kuittinen, O; Peltonen, J; Siniluoto, T; Sonkajärvi, E; Turpeenniemi-Hujanen, T1
Cao, F; Lan, W; Li, D; Li, J; Li, L; Li, Y; Liu, X; Meng, R; Shi, C; Wang, H; Yang, B; Zhang, Y; Zhang, Z; Zhao, H; Zhou, J1
Fishburne, BC; Neuwelt, EA; Rosenbaum, JT; Wilson, DJ1
Apollo, D; Barnett, G; Janigro, D; Kapural, M; Krizanac-Bengez, Lj; Masaryk, T; Mayberg, MR; Perl, J; Rasmussen, P1

Reviews

1 review(s) available for mannitol and Central Nervous System Neoplasm

ArticleYear
[Chemotherapy in conjunction with blood brain barrier disruption in the treatment of primary central nervous system lymphoma].
    Duodecim; laaketieteellinen aikakauskirja, 2013, Volume: 129, Issue:15

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Blood-Brain Barrier; Central Nervous System Neoplasms; Humans; Lymphoma; Mannitol

2013

Trials

1 trial(s) available for mannitol and Central Nervous System Neoplasm

ArticleYear
Arsenic trioxide and mannitol for the treatment of acute promyelocytic leukemia relapse in the central nervous system.
    Blood, 2014, Sep-18, Volume: 124, Issue:12

    Topics: Adolescent; Adult; Arsenic Trioxide; Arsenicals; Blood-Brain Barrier; Central Nervous System Neoplasms; Child; Female; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Male; Mannitol; Middle Aged; Oxides; Recurrence; Remission Induction; Young Adult

2014

Other Studies

5 other study(ies) available for mannitol and Central Nervous System Neoplasm

ArticleYear
Risk Factors and Disease Course for Blood-Brain Barrier Disruption-Associated Maculopathy.
    JAMA ophthalmology, 2021, 02-01, Volume: 139, Issue:2

    Topics: Adult; Antineoplastic Agents; Blood-Brain Barrier; Capillary Permeability; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Injections; Macular Degeneration; Male; Mannitol; Middle Aged; Osmosis; Retrospective Studies; Risk Assessment; Risk Factors

2021
Blood-brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 05-04, Volume: 118, Issue:18

    Topics: Animals; Blood-Brain Barrier; Carotid Arteries; Cell Adhesion; Cell Adhesion Molecules; Central Nervous System Neoplasms; Chemokines; Cytokines; Endothelial Cells; Humans; Immunity, Innate; Inflammation; Mannitol; Rats; Tight Junctions

2021
Real-time monitoring of human blood-brain barrier disruption.
    PloS one, 2017, Volume: 12, Issue:3

    Topics: Adult; Aged; Anesthesia; Antineoplastic Agents; Blood-Brain Barrier; Capillary Permeability; Carotid Arteries; Central Nervous System Neoplasms; Electroencephalography; Female; Hemoglobins; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Mannitol; Middle Aged; Neurophysiological Monitoring; Oxyhemoglobins; Spectroscopy, Near-Infrared; Vertebral Artery; Young Adult

2017
Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1997, Volume: 115, Issue:9

    Topics: Aged; Antimetabolites, Antineoplastic; Blood-Brain Barrier; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Diuretics, Osmotic; Eye Neoplasms; Female; Humans; Injections; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Survival Rate; Visual Acuity; Vitreous Body

1997
Serum S-100beta as a possible marker of blood-brain barrier disruption.
    Brain research, 2002, Jun-14, Volume: 940, Issue:1-2

    Topics: Biomarkers; Blood-Brain Barrier; Central Nervous System Neoplasms; Drug Administration Schedule; Humans; Infusions, Intra-Arterial; Lymphoma; Mannitol; Nerve Growth Factors; Phosphopyruvate Hydratase; Predictive Value of Tests; S100 Calcium Binding Protein beta Subunit; S100 Proteins

2002